Cargando…

Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia

With the treatment advances over the last three decades, acute promyelocytic leukemia (APL) has evolved from being the most malignant form of acute leukemia to a leukemia with excellent long term survival rates. In the present review, we have summarized data leading to the development of the current...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulkarni, Uday, Mathews, Vikram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947681/ https://www.ncbi.nlm.nih.gov/pubmed/33718181 http://dx.doi.org/10.3389/fonc.2021.621566

Ejemplares similares

Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale
por: Masetti, Riccardo, et al.
Publicado: (2023)

Intracranial bleeding in acute promyelocytic leukemia treated with arsenic trioxide based regimens is associated with induction mortality but not with relapse
por: Kulkarni, Uday Prakash, et al.
Publicado: (2023)

Editorial: Acute Promyelocytic Leukemia — Towards A Chemotherapy-Free Approach to Cure in All Patients
por: Gill, Harinder, et al.
Publicado: (2022)

The History of the Chemo-Free Model in the Treatment of Acute Promyelocytic Leukemia
por: Zhu, Hong-Hu
Publicado: (2020)

The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome
por: LaBella, Dominic, et al.
Publicado: (2022)

Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II
por: Gill, Harinder, et al.
Publicado: (2023)

Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
por: Sun, Jianai, et al.
Publicado: (2020)

Therapeutic Approaches for Acute Promyelocytic Leukaemia: Moving Towards an Orally Chemotherapy-Free Era
por: Xu, Zheng-Li, et al.
Publicado: (2020)

SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
por: Turcas, Cristina, et al.
Publicado: (2020)

Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
por: Balasundaram, Nithya, et al.
Publicado: (2022)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011)

Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens
por: Fouzia, N. A., et al.
Publicado: (2020)

Pediatric Acute Promyelocytic Leukemia: Epidemiology, Molecular Features, and Importance of GST-Theta 1 in Chemotherapy Response and Outcome
por: Andrade, Francianne G., et al.
Publicado: (2021)

Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
por: Sanz, Jaime, et al.
Publicado: (2021)

The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions
por: Iyer, Sunil Girish, et al.
Publicado: (2023)

Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia
por: Rodríguez-Rodríguez, Sergio, et al.
Publicado: (2021)

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy
por: Gurnari, Carmelo, et al.
Publicado: (2021)

Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia
por: Lou, Yinjun, et al.
Publicado: (2021)

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

Case report: A rare case of acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia
por: Zhao, Junmei, et al.
Publicado: (2022)

Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia
por: Kulkarni, Uday P., et al.
Publicado: (2022)

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
por: de Almeida, Luciana Yamamoto, et al.
Publicado: (2021)

Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report
por: Zhang, Xuzhao, et al.
Publicado: (2021)

Metachronous Multiple Primary Carcinoma With Acute Promyelocytic Leukemia: 2 Cases Report and Literature Review
por: Wang, Cong, et al.
Publicado: (2022)

A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide
por: Kulkarni, Uday, et al.
Publicado: (2020)

Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020)

Case Report: Very Late, Atypical Extra-Medullary Relapse in a Patient With Acute Promyelocytic Leukemia (APL) Rescued With a Transplant-Free Approach
por: Molica, Matteo, et al.
Publicado: (2021)

Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia
por: Ueda, Masumi, et al.
Publicado: (2020)

Acute Promyelocytic Leukemia Presenting With a Myeloid Sarcoma of the Spine: A Case Report and Literature Review
por: Shu, Xuemei, et al.
Publicado: (2022)

Coagulation Abnormalities and Risk Assessment in Acute Promyelocytic Leukemia: An Experience From a Resource-Constraint Country
por: Thakur, Warkha, et al.
Publicado: (2022)

Long-term experience in treatment of acute promyelocytic leukemia in Mexican children in a tertiary care hospital
por: Murillo-Maldonado, Marco Antonio, et al.
Publicado: (2023)

Successful Management of Acute Promyelocytic Leukemia in a Patient Who Presented With Acute Ischemic Stroke on Top of Subdural Hematoma
por: Mallah, Shatha, et al.
Publicado: (2023)

The Promyelocytic Leukemia Zinc Finger Protein: Two Decades of Molecular Oncology
por: Suliman, Bandar Ali, et al.
Publicado: (2012)

Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia
por: Wen, Jingjing, et al.
Publicado: (2022)

Torque teno mini virus driven childhood acute promyelocytic leukemia: The third case report and sequence analysis
por: Chen, Xue, et al.
Publicado: (2022)

Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement
por: Ding, Wenjing, et al.
Publicado: (2023)

Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features
por: Suzuki, Tomotaka, et al.
Publicado: (2023)

Complications during Induction Chemotherapy in Acute Promyelocytic Leukemia: An Institutional Experience
por: Yedla, Rajani Priya, et al.
Publicado: (2022)

History of Acute Promyelocytic Leukemia
por: Sanz, Miguel A., et al.
Publicado: (2021)

Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis
por: Alex, Ansu Abu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e52qeqrh02r0i15u4mubd2oef0